Published in Am J Hum Genet on March 01, 1994
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83
Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62
High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation. Hum Mutat (2015) 1.61
High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet (2004) 1.47
Unequal meiotic crossover: a frequent cause of NF1 microdeletions. Am J Hum Genet (2000) 1.40
Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet (2007) 1.10
NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet (2000) 1.09
Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer (2007) 1.07
Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06
Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH. Hum Mutat (2011) 1.01
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet (2014) 1.00
Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet (1996) 1.00
Brief report: the association of neurofibromatosis type 1 and autism. J Autism Dev Disord (1998) 0.99
Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. Am J Hum Genet (2001) 0.99
Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet (1998) 0.97
Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet (2006) 0.96
Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet (1998) 0.95
Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. Am J Hum Genet (2007) 0.94
Extensively high load of internal tumors determined by whole body MRI scanning in a patient with neurofibromatosis type 1 and a non-LCR-mediated 2-Mb deletion in 17q11.2. Hum Genet (2005) 0.94
Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. J Med Genet (2006) 0.93
Chromosomal phenotypes and submicroscopic abnormalities. Hum Genomics (2004) 0.91
Monozygotic twins discordant for neurofibromatosis 1. Am J Med Genet A (2010) 0.91
A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay. J Med Genet (1996) 0.89
Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types. Fam Cancer (2007) 0.86
Back to the future: proceedings from the 2010 NF Conference. Am J Med Genet A (2010) 0.84
A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am J Hum Genet (1998) 0.83
Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features. J Med Genet (1999) 0.81
Arg(1809) substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1. Eur J Hum Genet (2015) 0.81
A Combined Omics Approach to Generate the Surface Atlas of Human Naive CD4+ T Cells during Early T-Cell Receptor Activation. Mol Cell Proteomics (2015) 0.79
Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis. J Med Genet (2013) 0.78
Familial neurofibromatosis type 1 associated with an overgrowth syndrome resembling Weaver syndrome. J Med Genet (1998) 0.77
Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet (2017) 0.75
Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis. Stem Cells Int (2012) 0.75
A novel NF1 gene mutation in an Italian family with neurofibromatosis type 1. Childs Nerv Syst (2010) 0.75
Two pathogenic NF1 gene mutations identified in DNA from a child with mild phenotype. Childs Nerv Syst (2011) 0.75
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet (1989) 62.23
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (1990) 8.91
Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol (1988) 8.61
A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell (1990) 8.10
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell (1990) 6.94
The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell (1990) 5.24
Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell (1990) 4.84
A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet (1986) 4.65
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42
Noonan syndrome. J Med Genet (1987) 3.70
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
A de novo Alu insertion results in neurofibromatosis type 1. Nature (1991) 3.29
Precise localization of NF1 to 17q11.2 by balanced translocation. Am J Hum Genet (1989) 3.27
Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell (1992) 3.20
Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation. Cell (1993) 3.16
An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet (1993) 2.79
Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res (1990) 2.62
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet (1993) 2.10
Deletion and amplification of the HGPRT locus in Chinese hamster cells. Mol Cell Biol (1983) 2.10
Multipoint linkage analysis in neurofibromatosis type I: an international collaboration. Am J Hum Genet (1989) 2.04
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet (1989) 1.87
Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics (1987) 1.73
Tightly linked markers for the neurofibromatosis type 1 gene. Genomics (1987) 1.68
The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations. Genomics (1990) 1.66
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
Noonan phenotype associated with neurofibromatosis. Am J Med Genet (1985) 1.53
The neurofibromatosis-Noonan syndrome. Am J Med Genet (1985) 1.49
Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet (1993) 1.48
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet (1993) 1.45
Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol (1990) 1.29
The neurofibromatosis-Noonan syndrome. Am J Med Genet (1985) 1.27
X-linked severe combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis. Am J Hum Genet (1989) 1.26
An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1). Nucleic Acids Res (1991) 1.19
The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J Cell Biol (1990) 1.19
Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet (1993) 1.19
Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet (1992) 1.09
Lymphedema in Noonan syndrome: clues to pathogenesis and prenatal diagnosis and review of the literature. Am J Med Genet (1987) 1.09
A 90 kb DNA deletion associated with neurofibromatosis type 1. J Med Genet (1990) 1.07
Analysis of mutations at the neurofibromatosis 1 (NF1) locus. Hum Mol Genet (1992) 1.07
Linkage studies with chromosome 17 DNA markers in 45 neurofibromatosis 1 families. Genomics (1987) 1.05
Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet (1992) 1.03
cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene. Genomics (1991) 1.02
Rapid nonradioactive detection by PCR of pHHH202/RsaI RFLP linked to neurofibromatosis type I. Am J Hum Genet (1991) 1.00
Neurofibromatosis with fully expressed Noonan syndrome. Am J Med Genet (1988) 0.98
The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. Mol Cell Biol (1991) 0.97
The neurofibromatosis type 1 gene. Annu Rev Neurosci (1993) 0.96
Genetic analysis of eight loci tightly linked to neurofibromatosis 1. Am J Hum Genet (1989) 0.91
Evidence that the "neurofibromatosis-Noonan syndrome" is a variant of von Recklinghausen neurofibromatosis. Am J Med Genet (1987) 0.90
Refined physical and genetic mapping of the NF1 region on chromosome 17. Am J Hum Genet (1989) 0.90
Clinical variability of type 1 neurofibromatosis: is there a neurofibromatosis-Noonan syndrome? J Med Genet (1992) 0.90
Vertical transmission of the neurofibromatosis/Noonan syndrome. Am J Med Genet (1987) 0.90
Analysis of segregation and expression of an identified mutation at the neurofibromatosis type 1 locus. Hum Genet (1992) 0.88
NF1-related locus on chromosome 15. Genomics (1992) 0.88
Immunochemical studies of organ and tumor lipids: VIII. Comparison of human tumor and ox spleen cytosides. J Lipid Res (1960) 0.83
A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene. Genomics (1992) 0.83
Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1. Hum Genet (1991) 0.81
The gene for a novel epidermal antigen maps near the neurofibromatosis 1 gene. Genomics (1992) 0.81
Pathogenesis of congenital defects associated with Turner's syndrome: the role of hypoalbuminemia and edema. Acta Endocrinol Suppl (Copenh) (1986) 0.80
Molecular analysis of neurofibromatosis type 1 mutations. Hum Mutat (1992) 0.77
Linkage analysis of neurofibromatosis type 1. Study of a homogeneous North Italian population with five DNA markers of chromosome 17. Hum Genet (1991) 0.77
A genetic linkage map of the human genome. Cell (1987) 13.37
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Von Recklinghausen neurofibromatosis. N Engl J Med (1981) 7.69
Mission critical--integrating clinician-educators into academic medical centers. N Engl J Med (1999) 6.41
Effects of the RAD52 Gene on Recombination in SACCHAROMYCES CEREVISIAE. Genetics (1980) 6.07
Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med (1981) 4.25
Informed consent for population-based research involving genetics. JAMA (2001) 4.10
A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience (2005) 3.41
Research ethics. Research practice and participant preferences: the growing gulf. Science (2011) 3.27
ASHG activities relative to education: Human genetics as a component of medical school curricula: A report to the American society of human genetics. Am J Hum Genet (1988) 3.24
Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics (1978) 3.04
Health services research for decision-makers: the use of the Delphi technique to determine health priorities. J Health Polit Policy Law (1977) 2.79
Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet (1999) 2.71
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A (1990) 2.52
Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet (1977) 2.48
Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases. Am J Hum Genet (1982) 2.44
A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology (2000) 2.44
Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer (1982) 2.43
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther (2007) 2.38
The complexities of predictive genetic testing. BMJ (2001) 2.36
Infection in social networks: using network analysis to identify high-risk individuals. Am J Epidemiol (2005) 2.31
Turning interns into senior residents: preparing residents for their teaching and leadership roles. Acad Med (1995) 2.31
HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol (2001) 2.24
Effect of improved sanitary facilities on infant diarrhea in a Hopi village. Public Health Rep (1969) 2.20
Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet (1979) 2.18
Morphogenetic movements and multicellular development in the fruiting Myxobacterium, Stigmatella aurantiaca. Dev Biol (1978) 2.12
Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin Genet (2012) 2.07
Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem (1991) 2.07
Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin. Diabetes (1968) 2.07
A structurally abnormal insulin causing human diabetes. Nature (1979) 1.99
Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology (2002) 1.90
Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med (1979) 1.88
Light-stimulated morphogenesis in the fruiting myxobacterium Stigmatella aurantiaca. Science (1978) 1.88
Is Clostridium difficile endemic in chronic-care facilities? Lancet (1986) 1.88
A link between cell movement and gene expression argues that motility is required for cell-cell signaling during fruiting body development. Genes Dev (1988) 1.82
Internet access to patients' records. Lancet (1998) 1.80
Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet (2000) 1.76
Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.74
Neuropsychiatric problems in systemic lupus erythematosus. Br Med J (1972) 1.74
Optimal screening mammography reading volumes; evidence from real life in the East Midlands region of the NHS Breast Screening Programme. Clin Radiol (2010) 1.72
A cost-benefit analysis of culling badgers to control bovine tuberculosis. Vet J (2006) 1.72
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet (1996) 1.70
Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science (1981) 1.70
Pheromone produced by the myxobacterium Stigmatella aurantiaca. J Bacteriol (1982) 1.67
Report of the Task Force on Teaching Human Genetics in North American Medical Schools. Am J Hum Genet (1989) 1.65
A keratin 14 mutational hot spot for epidermolysis bullosa simplex, Dowling-Meara: implications for diagnosis. J Invest Dermatol (1993) 1.64
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis (1993) 1.63
Effects of female relative support in labor: a randomized controlled trial. Birth (1999) 1.62
Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet (2001) 1.61
The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations. Am J Med Genet (1984) 1.60
Integrating clinician-educators into Academic Medical Centers: challenges and potential solutions. Acad Med (2000) 1.57
Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology (1981) 1.55
What internists need to know: core competencies in women's health. ABIM Subcommittee on Clinical Competence in Women's Health. Am J Med (1997) 1.55
Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol (2008) 1.53
Increase in desipramine serum levels associated with methadone treatment. Am J Psychiatry (1989) 1.53
NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet (2000) 1.53
Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest (1993) 1.52
A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban. Biophys J (1999) 1.50
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev (1999) 1.49
Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am J Hum Genet (1994) 1.48
Primary care internal medicine: a challenging career choice for the 1990s. Ann Intern Med (1990) 1.45
Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. JAMA (1992) 1.43
Skin, blood, nerve cells, and heritability. New lessons from neurofibromatosis type 1. Arch Dermatol (1995) 1.40
Three mutant insulins in man. Nature (1983) 1.40
Fostering a new relationship between departments of medicine and teaching hospitals. Acad Med (1993) 1.39
If you care about women's health, perhaps you should care about the risks of direct marketing of tamoxifen to consumers. Eff Clin Pract (2000) 1.39
A comparison of the pharmacokinetics of 14C-labelled APD and 99mTc-labelled APD in the mouse. Calcif Tissue Int (1988) 1.38
Raman spectroscopic method for identification of clinically relevant microorganisms growing on solid culture medium. Anal Chem (2000) 1.38
Health care and disease prevention through genetic counseling: a regional approach. Am J Public Health (1976) 1.37
Survival in scleroderma. Ann Rheum Dis (1971) 1.37
The advent of the "unpatients'. Nat Med (1996) 1.36
Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J (2007) 1.34
Disuse in the lateral geniculate nucleus of the cat. J Physiol (1968) 1.33
von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology (1984) 1.32
Food production, population growth, and the environment. Science (1998) 1.32
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br J Cancer (2011) 1.31
Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol (1990) 1.28
Address in Pathology, ON CHEMIOTHERAPY: Delivered before the Seventeenth International Congress of Medicine. Br Med J (1913) 1.28
The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes (1986) 1.27
Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet (1996) 1.27
Gene dose effect: intraband mapping of the LDH A locus using cells from four individuals with different interstitial deletions of 11p. Cytogenet Cell Genet (1977) 1.27
The FG syndrome: further characterization, report of a third family, and of a sporadic case. Am J Med Genet (1977) 1.27
Neurofibromatosis: variable expression is not intrinsic to the mutant gene. Birth Defects Orig Artic Ser (1979) 1.26
Reduction of biogenic amine levels in the Rett syndrome. N Engl J Med (1985) 1.26
Temporal order in yeast chromosome replication. Cell (1975) 1.25
Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study. Semin Arthritis Rheum (1990) 1.24
Oculocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-Willi syndrome. Am J Ophthalmol (1982) 1.22
Neurofibromatosis: past, present, and future. N Engl J Med (1991) 1.21
A cross-national comparison of the institutionalized elderly in the cities of New York and London. Psychol Med (1979) 1.20
Plasticity in adult cat visual cortex (area 17) following circumscribed monocular lesions of all retinal layers. J Physiol (2000) 1.18
The order of loci in the pericentric region of chromosome 17, based on evidence from physical and genetic breakpoints. Am J Hum Genet (1989) 1.18
Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol (1987) 1.18
Long range physical map of the Wilms' tumor-aniridia region on human chromosome 11. Cell (1988) 1.18
Predicting the volume of health and social services: integrating cognitive impairment into the modified Andersen framework. Gerontologist (1992) 1.17
A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med (1998) 1.16
Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Proc Natl Acad Sci U S A (1980) 1.16
Preventive medicine through genetic counseling: a regional program. Prev Med (1975) 1.15
Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol (1984) 1.15
Indole glucosinolate and auxin biosynthesis in Arabidopsis thaliana (L.) Heynh. glucosinolate mutants and the development of clubroot disease. Planta (1999) 1.15
Discharge patterns of principal cells and interneurones in lateral geniculate nucleus of rat. J Physiol (1966) 1.15